{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreigp46nro3hymrdir2uzpyahkmkgspupqn3oyvzlmnnz3733spwca4",
    "uri": "at://did:plc:ox2kiwcr2xmn32p25g472pp7/app.bsky.feed.post/3mkzlr3wzyan2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreigflnqnu4wqitsq3myipkak4ki2lcrls6lfywfcmel2liipvt24qa"
    },
    "mimeType": "image/webp",
    "size": 294316
  },
  "path": "/releases/2026/05/260502233924.htm",
  "publishedAt": "2026-05-04T02:14:05.000Z",
  "site": "https://www.sciencedaily.com",
  "textContent": "GLP-1 drugs like semaglutide—best known for treating diabetes and driving weight loss under the brand names Ozempic and Wegovy—may also deliver a surprising mental health boost. In a massive study tracking nearly 100,000 people over more than a decade, researchers found that these medications were linked to significantly fewer psychiatric hospital visits and sick days.",
  "title": "Weight loss drug Ozempic linked to lower depression and anxiety risk"
}